Table Of Contents

1. Introduction 11
1.1. Objectives Of The Study 11
1.2. Market Definition 11
1.3. Overview Of U.S. Skin Graft Market 11
1.4. Currency And Pricing 12
1.5. Limitation 12
1.6. Markets Covered 13
2. Market Segmentation 14
2.1. Markets Covered 14
2.2. Years Considered For The Study 15
2.3. Currency And Pricing 15
2.4. Research Methodology 16
2.5. Primary Interviews With Key Opinion Leaders 19
2.6. Secondary Sources 20
2.7. Assumptions 20
3. Market Overview 21
3.1. Drivers 23
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers, And Skin Infections 23
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques 24
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure 25
3.2. Restraints 26
3.2.1. Side Effects Related To The Skin Graft Procedure 26
3.3. Opportunities 27
3.3.1. Increasing Medical Tourisms 27
3.4. Challenges 28
3.4.1. Competition Among Major Players In The U.S. 28
4. Executive Summary 29
5. Premium Insights 31
6. U.S. Skin Graft Market, By Type 33
6.1. Overview 34
6.2. Autologous 35
6.3. Isogeneic 36
6.4. Allogeneic 36
6.5. Xenogeneic 36
6.6. Prosthetic 37
7. U.S. Skin Graft Market, By Graft Thickness 38
7.1. Overview 39
7.2. Split-Thickness 41
7.3. Full-Thickness 41
7.4. Composite Graft 41
8. U.S. Skin Graft Market, By Application 42
8.1. Overview 43
8.2. Extensive Wound 45
8.3. Extensive Skin Loss Due To Infection 45
8.4. Skin Cancer 46
8.5. Burns 46
9. U.S. Skin Graft Market, By Equipment Type 47
9.1. Overview 48
9.2. Dermatome 49
9.2.1. Knife Dermatomes 50
9.2.1.1. Blair/Brown Knife 51
9.2.1.2. Watson Knife 51
9.2.1.3. Cobbett Knife 52
9.2.2. Drum Dermatomes 52
9.2.2.1. Padgett Dermatomes 53
9.2.2.2. Reese Dermatomes 53
9.2.3. Electrical Dermatomes 53
9.2.4. Air-Powdered Dermatomes 54
9.3. General Surgical Instruments 55
9.4. Consumables 55
9.5. Others 55
10. U.S. Skin Graft Market, By End User 56
10.1. Overview 57
10.2. Hospitals 59
10.3. Dermatology Clinics 59
10.4. Ambulatory Surgical Centers 59
11. U.S. Skin Graft Market, Company Landscape 60
11.1. Company Share Analysis; North America 60
12. Company Profiles 61
12.1. Organogenesis Inc. 61
12.1.1. Company Overview 61
12.1.2. Organogenesis Inc.; Company Snapshot 61
12.1.3. Product Portfolio 62
12.1.4. Recent Developments 62
12.2. Integra Lifesciences Corporation 63
12.2.1. Company Overview 63
12.2.2. Integra Lifesciences Corporation; Revenue Analysis 63
12.2.3. Product Portfolio 64
12.2.4. Recent Developments 65
12.3. Zimmer Biomet 66
12.3.1. Company Overview 66
12.3.2. Zimmer Biomet; Revenue Analysis 66
12.3.3. Product Portfolio 67
12.3.4. Recent Developments 67
12.4. B. Braun Melsungen Ag 68
12.4.1. Company Overview 68
12.4.2. B. Braun Melsungen Ag; Revenue Analysis 68
12.4.3. Product Portfolio 69
12.4.4. Recent Developments 69
12.5. Avita Medical 70
12.5.1. Company Overview 70
12.5.2. Avita Medical ;Revenue Analysis 70
12.5.3. Product Portfolio 71
12.5.4. Recent Developments 71
12.6. De Soutter Medical 72
12.6.1. Company Overview 72
12.6.2. De Soutter Medical; Company Snapshot 72
12.6.3. Product Portfolio 73
12.6.4. Recent Developments 73
12.7. Exsurco Medical, Inc. 74
12.7.1. Company Overview 74
12.7.2. Exsurco Medical, Inc.;Company Snapshot 74
12.7.3. Product Portfolio 75
12.7.4. Recent Developments 75
12.8. Mallinckrodt 76
12.8.1. Company Overview 76
12.8.2. Mallinckrodt; Revenue Analysis 76
12.8.3. Product Pipeline 77
12.8.4. Recent Developments 77
12.9. Nouvag 78
12.9.1. Company Overview 78
12.9.2. Nouvag; Company Snapshot 78
12.9.3. Product Portfolio 79
12.9.4. Recent Developments 79
12.10. Surtex Instruments Limited 80
12.10.1. Company Overview 80
12.10.2. Surtex Instruments Limited; Company Snapshot 80
12.10.3. Product Portfolio 81
12.10.4. Recent Developments 81
12.11. Tissue Regenix 82
12.11.1. Company Overview 82
12.11.2. Tissue Regenix; Revenue Analysis 82
12.11.3. Product Portfolio 83
12.11.4. Recent Developments 83
13. Related Reports 84
?